Oslo Patient Becomes Tenth Person Reported Cured of HIV After Stem Cell Transplant

Oslo Patient Becomes Tenth Person Reported Cured of HIV After Stem Cell Transplant
Why this is good news

    A man in Oslo is the tenth person cured of HIV, a virus that attacks the immune system, after a special stem cell transplant for his blood cancer.

  • Ten Confirmed Cures.Before this, only nine people were known to be cured of HIV. This tenth case confirms the cure is a repeatable outcome, not a one-time fluke, strengthening the scientific proof.
  • Brother Donor Success.Previous cures required donors with a rare HIV-blocking gene mutation. This patient was cured using cells from his brother who lacked that mutation, proving a cure is possible through a different biological pathway.
  • Five-Year Virus-Free Milestone.The patient has had no detectable, replicating HIV for over five years after stopping antiviral drugs. This long-term remission moves him from "in treatment" to being declared functionally cured.
  • Blueprint for Safer Therapies.Stem cell transplants are too risky for most HIV patients. This case provides crucial data on how the immune system clears HIV without the protective mutation, guiding researchers toward replicating the cure with gentler gene therapies.

A man in Oslo has become the latest person in the world to be declared functionally cured of HIV, marking the tenth such reported case and offering new insights into the complex path toward eradicating the virus. The patient, who was also being treated for a rare blood cancer, has shown no detectable, replicating HIV for over five years after a stem cell transplant from his brother.

The 63-year-old patient, diagnosed with HIV in 2006, later developed myelodysplastic syndrome, a type of blood cancer. To treat this cancer, doctors at Oslo University Hospital performed an allogeneic hematopoietic stem cell transplant (HSCT), using cells from his brother. Crucially, the donor was found to carry a rare genetic mutation known as CCR5Δ32/Δ32. This mutation removes the receptor proteins on immune cells that most strains of HIV use to enter and infect them. Two years after the transplant, the patient safely stopped his antiretroviral therapy. Extensive analysis of over 65 million of his cells found no functional HIV DNA and no signs that the virus could rebound.

While the outcome is a significant medical breakthrough, researchers caution that this method is not a scalable cure for the millions living with HIV worldwide. The procedure itself is high-risk, with between 10 and 20% of transplant recipients dying within a year. It requires a donor who is both a close genetic match and carries the rare CCR5 mutation, a combination that is exceedingly difficult to find. Furthermore, the patient experienced graft-versus-host disease, a severe immune reaction where donor cells attack the recipient's body, though this reaction may have also helped eliminate HIV-infected cells.

Moving forward, scientists emphasize that the case provides invaluable data. They aim to compare all known cure cases to identify the precise biomarkers and mechanisms that lead to long-term remission. The hope is that this knowledge can inform less invasive, more widely applicable strategies for an HIV cure. For now, the case of the Oslo patient stands as a powerful proof of concept and a beacon for ongoing research, demonstrating that a cure, however complex, is scientifically possible.

This article is for informational purposes only and does not constitute medical advice. The information presented is based on published research and official announcements. Always consult a qualified healthcare professional before making any medical decisions.

← Back to all stories
Medical Disclaimer: Content on Curative News is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.